Selecta Biosciences is a clinical-stage biopharmaceutical company that develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its lead therapeutic gene therapy program is SEL-302, and it is also developing biologic therapies and gene therapies for various diseases. The company has license and collaboration agreements with several pharmaceutical companies and is headquartered in Watertown, Massachusetts.
Featured Jobs
Related Companies
Other Resources